Regeneron Pharmaceuticals Up Over 12%, on Track for Highest Close Since October 2024 -- Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $917.34, up $98.57 or 12.04%

--Would be highest close since Oct. 30, 2024, when it closed at $922.79

--On pace for largest percent increase since Sept. 8, 2022, when it rose 18.85%

--Currently up four of the past five days

--Currently up two consecutive days; up 12.8% over this period

--Best two day stretch since the two days ending Oct. 28, 2025, when it rose 13.24%

--Up 13.95% this week; best weekly performance since the week ending July 31, 2026, when it rose 16.25%

--Up 20.98% month-to-date; on pace for best month since July 2026, when it rose 22.31%

--Up 18.85% year-to-date; on pace for best year since 2023, when it rose 21.73%

--Down 23.67% from its all-time closing high of $1201.76 on Aug. 27, 2024

--Up 40.74% from 52 weeks ago (Oct. 31, 2025), when it closed at $651.80

--Would be a new 52-week closing high

--Up 52.72% from its 52-week closing low of $600.66 on June 1, 2026

--Traded as high as $935.35; highest intraday level since Oct. 30, 2024, when it hit $935.86

--Up 14.24% at today's intraday high; largest intraday percent increase since Sept. 8, 2022, when it rose as much as 20.54%

--Best performer in the S&P 500 today

--Best performer in the Nasdaq 100 today

All data as of 10:01:56 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 30, 2026 10:04 ET (14:04 GMT)